Amazon’s nuclear plan for its AI operations has fuelled debate about Australia’s energy future, with tech leaders warning we ...

CSL analysts reckon the healthcare giant is undervalued after Tuesday's market hiding, but remain bearish about a near-term ...

The ASX was cruising early before a hotter-than-expected CPI smacked the rally. Meanwhile CSL was bruised again, but Boss ...

If house prices keep rising at current rates, retiring with a mortgage will be commonplace, writes James Kirby.

Drug developers have been acquiring complimentary programs to reduce execution risk and maintain investor interest.

Quarterly season is almost done, and David Franklyn joins to give his best and worst September gold performers, plus a ...

The ASX 200 was looking a little unsteady this morning, overloaded by a barrage of quarterlies as reporting season kicks off ...

Macquarie Bank’s provision of funding for QPM Energy’s Issac Power Station is a sign that east coast plays could have more ...

Ark Mines (ASX:AHK) is close to completing groundwork at the Sandy Mitchell project as environmental baseline studies ...

Wellness has gone to a trillion-dollar lifestyle, and EZZ Life Science is diving straight into America’s booming self-care ...

In this latest episode of Stockhead’s Who’s Who on the ASX, host Tylah Tully spotlights Codeifai (ASX:CDE). Codeifai offers ...